project id: TCGA-BRCA; case submitter id: TCGA-S3-AA0Z; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 8.9; age at index: 63; days to birth: -23314; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1950; age at diagnosis: 23314; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 629.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 204; days to sample procurement: 0; initial weight: 330.0; portion submitter id: TCGA-S3-AA0Z-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 2.0; percent stromal cells: 8.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;